Back to search
FDAFDA · Food and drugs·Recall number D-1256-2020

Esomeprazole Magnesium Delayed Release Capsules USP, 40 mg*, 1000-count bottles, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 INDIA, NDC 43598-510-10

Published May 6, 2020 · Recall initiated: April 24, 2020

Summary

FDA records drug Class III recall D-1256-2020, published May 6, 2020 and initiated April 24, 2020. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 1752 bottles; Lot: Lot #: C900642, Exp. 06/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Discoloration: product contains brown pellets

What to do

Voluntary: Firm initiated · Letter

Get an email if ESOMEPRAZOLE MAGNESIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ESOMEPRAZOLE MAGNESIUM
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide within the United States
Lot
Lot #: C900642, Exp. 06/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Esomeprazole Magnesium Delayed Release Capsules USP, 40 mg*, 1000-count bottles, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 INDIA, NDC 43598-510-10 recalled?

Yes. FDA published recall D-1256-2020 on May 6, 2020. Reported hazard: Discoloration: product contains brown pellets

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ESOMEPRAZOLE MAGNESIUM.